Clinical trial

G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients

NCT00401609 · National Cancer Institute, Naples, Other · Completed

Key facts

NCT number NCT00401609
Title G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients
Official title Evaluation of Activity and Toxicity of Polychemotherapy With 2-drug Combinations Containing Gemcitabine as First Line Treatment of Elderly Patients With Small Cell Lung Cancer
Acronym G-Step
Lead sponsor National Cancer Institute, Naples, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Small Cell Lung Cancer
Intervention type Drug
Interventions gemcitabine, vinorelbine, cisplatin, etoposide, carboplatin
Enrollment 85
Start date Nov 1, 2000
Primary completion Dec 1, 2007
Completion Feb 1, 2009
First posted Nov 20, 2006
Last update posted Jan 14, 2016
Countries Italy

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies